Aura Biosciences (AURA) Interest Coverage Ratio (2022)
Aura Biosciences' (AURA) quarterly Interest Coverage Ratio came in at 1.48 in Q1 2026, up 86.74% YoY from 0.79 in Q1 2025, and up 95.42% on a QoQ basis from 32.39 in Q4 2025.
Analysis
Aura Biosciences (AURA) Interest Coverage Ratio (2022) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Interest Coverage Ratio data on file, last reported at 1.48 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 86.74% year-over-year to 1.48 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.05 (up 87.26% YoY) and the FY2025 annual result came in at 34.12, down 186.38% from the prior year.
- Interest Coverage Ratio grew to 1.48 in Q1 2026, from 32.39 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.21 in Q1 2022 to a low of 34.04 in Q4 2024.
- A 5-year average of 8.78 and a median of 1.79 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 99.69% — and 2023, when it tumbled 636.27%.
- Tracing AURA's Interest Coverage Ratio over 5 years: stood at 22.93 in 2022, then plunged by 36.27% to 31.25 in 2023, then dropped by 8.91% to 34.04 in 2024, then climbed by 4.85% to 32.39 in 2025, then jumped by 95.42% to 1.48 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.48 (Q1 2026), 32.39 (Q4 2025), and 3.75 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 1.42 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.08 |
| 10 | Aura Biosciences | 711.48 Mn | 643.64 Mn | - | - |